Announcement on Abnormal Fluctuations in Stock Trading and Risk Alert
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Abnormal Fluctuations in Stock Trading and Risk Alert
Filed with SSE · · 3 pages · Chinese
Release
Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd on 6ix
Earlier from Hangzhou Tianmushan Pharmaceutical Enterprise
- Report for Q3 2024
- Announcement on Resolutions of the 5th Extraordinary General Meeting in 2024
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Convening the 2024 Semi-annual Performance Briefing
- Announcement on Receiving the Notice of Approval for Re-Registration of Drug
Later from Hangzhou Tianmushan Pharmaceutical Enterprise
- Announcement on the Renewal of the Drug Distribution License of Holding Subsidiary
- Announcement on Resolution of the 9th Meeting of the 12th Board of Directors
- Announcement on Progress in Shareholding Increase Plan for Shareholders with Over 5% Shares and Over Half of the Plan Period
- Announcement on Receiving Letter of Regulation from Shanghai Stock Exchange on Information Disclosure of the Company's Report for Q3 2024
- Announcement on Resolution of the 6th Extraordinary General Meeting in 2024
Follow Hangzhou Tianmushan Pharmaceutical Enterprise into a list and get an email when it puts out news.
Follow Hangzhou Tianmushan Pharmaceutical Enterprise